Sobhan Pharmaceuticals

Sobhan Pharmaceuticals is a prominent Iranian pharmaceutical conglomerate, primarily operating through its flagship subsidiaries Sobhan Darou and Sobhan Oncology. The company is a regional leader in the development and large-scale manufacturing of a broad range of therapeutic products, maintaining a dominant market share in central nervous system (CNS) and cardiovascular medications. Sobhan Oncology, a specialized division, focuses on the production of high-potency anti-cancer drugs, including both oral and injectable formulations, utilizing state-of-the-art facilities that comply with international GMP standards. As a key member of the Barakat Pharmaceutical Group, Sobhan Pharmaceuticals leverages extensive R&D capabilities to supply a diverse portfolio of over 100 generic and branded generic medicines. The company plays a critical role in the Middle Eastern healthcare infrastructure, focusing on both domestic supply and expanding export initiatives to neighboring markets.